Key Takeaways
- • Bunkerhill Health closed a Series B funding round led by Khosla Ventures with participation from Sequoia Capital, Felicis, Optum Ventures, and Y Combinator, bringing total funding to $55 million across Seed, Series A, and Series B rounds.
- • The company operates Carebricks, an agentic AI platform designed to enable health systems to deploy AI agents across operational workflows with unified infrastructure and rapid deployment capabilities.
- • Bunkerhill Health has secured partnerships with major U.S. health systems including Cleveland Clinic, University of Texas Medical Branch, and Intermountain Health, indicating institutional traction in the healthcare sector.
- • The funding round reflects investor confidence in agentic AI as foundational infrastructure for healthcare delivery transformation and operational optimization.
Summary
Bunkerhill Health, a San Francisco-based healthcare technology company, has completed its Series B funding round, marking a significant milestone in the adoption of agentic AI within health systems. The round was led by Khosla Ventures with continued support from existing investors Sequoia Capital, Felicis, Optum Ventures, and Y Combinator. The financing brings the company's cumulative funding to $55 million, demonstrating sustained investor confidence in the company's strategic positioning within the healthcare AI infrastructure market.
The company develops Carebricks, an agentic AI platform that provides health systems with a unified foundation for deploying autonomous AI agents across their operational spectrum. Rather than building isolated point solutions, Bunkerhill Health's platform approach enables health systems to accelerate innovation deployment while maintaining flexibility to adapt to evolving operational requirements. This architectural advantage positions the company to address a broad range of healthcare delivery challenges through a single integrated system.
Bunkerhill Health has established meaningful partnerships with established health system operators, including Cleveland Clinic, the University of Texas Medical Branch, and Intermountain Health. These relationships with nationally recognized providers validate demand for agentic AI infrastructure in production healthcare environments and suggest the company has achieved sufficient product maturity for enterprise adoption. The breadth and caliber of these partnerships underscore the perceived strategic value of the Carebricks platform within institutional healthcare delivery models.
The company develops Carebricks, an agentic AI platform that provides health systems with a unified foundation for deploying autonomous AI agents across their operational spectrum. Rather than building isolated point solutions, Bunkerhill Health's platform approach enables health systems to accelerate innovation deployment while maintaining flexibility to adapt to evolving operational requirements. This architectural advantage positions the company to address a broad range of healthcare delivery challenges through a single integrated system.
Bunkerhill Health has established meaningful partnerships with established health system operators, including Cleveland Clinic, the University of Texas Medical Branch, and Intermountain Health. These relationships with nationally recognized providers validate demand for agentic AI infrastructure in production healthcare environments and suggest the company has achieved sufficient product maturity for enterprise adoption. The breadth and caliber of these partnerships underscore the perceived strategic value of the Carebricks platform within institutional healthcare delivery models.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.